S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-4.11%)
F   8.90 (-0.56%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-4.11%)
F   8.90 (-0.56%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-4.11%)
F   8.90 (-0.56%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
T   38.00 (-4.11%)
F   8.90 (-0.56%)
BAC   32.94 (-0.06%)
DIS   148.38 (+0.49%)
Log in

Bio-Rad Laboratories Earnings Date, Estimates & History (NYSE:BIO)

$364.12
+5.84 (+1.63 %)
(As of 11/19/2019 04:00 PM ET)
Today's Range
$358.64
Now: $364.12
$365.79
50-Day Range
$320.26
MA: $342.64
$358.02
52-Week Range
$220.05
Now: $364.12
$365.79
Volume122,258 shs
Average Volume216,433 shs
Market Capitalization$10.90 billion
P/E Ratio62.35
Dividend YieldN/A
Beta1.16

Earnings

Bio-Rad Laboratories (NYSE:BIO) Earnings Information

Bio-Rad Laboratories last issued its earnings data on October 31st, 2019. The medical research company reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.25. The firm had revenue of $560.60 million for the quarter, compared to analysts' expectations of $561.40 million. Its revenue was up 2.8% compared to the same quarter last year. Bio-Rad Laboratories has generated $5.84 earnings per share over the last year and currently has a price-to-earnings ratio of 62.3. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.

Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates

2019 EPS Consensus Estimate: $7.40
2020 EPS Consensus Estimate: $9.33
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20191$1.76$1.76$1.76
Q2 20191$1.22$1.22$1.22
Q3 20191$1.77$1.77$1.77
Q4 20191$2.65$2.65$2.65
Q1 20201$2.04$2.04$2.04
Q2 20201$2.52$2.52$2.52
Q3 20201$2.23$2.23$2.23
Q4 20201$2.54$2.54$2.54

Bio-Rad Laboratories (NYSE BIO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/27/2020
(Estimated)
       
10/31/2019Q3$1.36$1.61$11.90$561.40 million$560.60 millionTranscript
8/1/2019Q2 2019$1.39$1.57($16.72)$564.88 million$572.60 millionListen
5/8/20193/31/2019$1.12$1.65($25.44)$548.82 million$553.98 millionListen
2/28/2019Q4 2018$1.61$2.13$32.14$610.65 million$617.54 millionN/A
11/1/20189/30/2018$1.16$0.91($7.07)$541.23 million$545.10 millionTranscript
8/7/2018Q2 2018$1.27$1.64($5.59)$551.05 million$575.91 millionN/A
5/8/2018Q1 2018$1.07$1.17($19.43)$527.20 million$551.52 millionN/A
2/27/2018Q4 2017$1.28$1.50$0.68$618.89 million$620.43 millionN/A
11/2/2017Q3 2017$0.54$0.91$0.91$507.99 million$535.00 millionN/A
8/3/2017Q2 2017$0.63$0.58$0.99$515.04 million$504.67 millionN/A
5/4/2017Q1 2017$0.27$0.41$0.41$477.76 million$500.05 millionListen
2/23/2017Q416$1.03($0.70)$3.20$574.40 million$571.45 millionN/A
11/1/2016Q316$0.51$0.62$0.62$480.60 million$508.75 millionN/A
8/3/2016Q2$1.13$0.61$0.61$497.80 million$516.80 millionN/A
5/5/2016Q1$0.60$0.42$0.42$463.90 million$471.20 millionN/A
2/25/2016Q415$1.27$1.68$1.68$570.80 million$570.56 millionListen
11/3/2015Q315$0.54$0.59$0.59$495.55 million$469.96 millionN/A
8/6/2015Q215$0.78$0.97$0.97$494.85 million$506.10 millionN/A
5/5/2015Q115$0.33$0.61$0.61$474.60 million$472.80 millionN/A
2/26/2015Q414$1.18$1.34$1.34$593.41 million$598.20 millionN/A
11/4/2014Q314$0.86$0.39$0.39$525.40 million$530.64 millionN/A
8/5/2014Q214$0.95$1.09$1.09$537.58 million$536.80 millionTranscript
5/6/2014Q114$0.80$0.23$0.23$515.00 million$509.30 millionN/A
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionListen
11/8/2013Q3 2013$0.66$0.56$1.37$529.02 million$505.10 millionListen
8/6/2013Q2 2013$1.12$1.20$1.20$532.60 million$525.30 millionListen
5/7/2013Q1 2013$1.10$0.68$0.68$506.34 million$499.70 millionN/A
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionTranscript
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionN/A
8/7/2012$1.19$1.69N/A
5/1/2012$1.02$1.09Transcript
2/23/2012$1.67$2.08N/A
11/1/2011$1.53$1.61N/A
8/2/2011$1.47$1.41N/A
5/3/2011$1.32$1.16N/A
2/24/2011$1.35$2.41N/A
11/2/2010Q3 2010$1.17$1.59$1.59N/A
8/3/2010Q2 2010$1.27$1.35$1.35N/A
5/4/2010Q1 2010$1.17$1.24$1.24N/A
2/24/2010Q4 2009$1.08$1.49$1.63N/A
11/3/2009Q3 2009$1.00$1.38$1.38N/A
8/4/2009Q2 2009$1.03$1.37$1.37N/A
5/5/2009Q1 2009$0.98$1.10$1.10N/A
2/26/2009Q4 2008$0.90$1.18$2.66N/A
11/6/2008Q3 2008$1.06$1.01$1.01N/A
8/5/2008Q2 2008$1.08$1.58$1.58N/A
5/6/2008Q1 2008$0.99$0.97$0.97N/A
2/28/2008Q4 2007$0.80$0.92$1.39N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Featured Article: What are earnings reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel